术后一年疼痛与阿片类药物使用轨迹:欧洲注册数据分析
该研究基于PAIN OUT注册的2326例混合手术患者,评估术前及术后6、12个月阿片使用与慢性疼痛。术后12个月阿片使用率为3.5%,慢性疼痛34.7%。与手术无关的慢性疼痛患者阿片使用率最高(22.3%),术前阿片使用是术后12个月阿片使用的最强相关因素。
要点
- 术后12个月阿片使用率低(3.5%),但慢性疼痛常见(34.7%)。
- 与手术无关的慢性疼痛患者阿片使用率最高(22.3%)。
- 术前阿片使用是术后12个月阿片使用的最强预测因素。
核心结论
- 慢性术后疼痛患者阿片使用率低,而与手术无关的慢性疼痛患者阿片使用问题更突出。
- 需详细评估慢性疼痛与手术的关系以指导术后阿片管理。
研究设计与样本
- 基于PAIN OUT注册的混合手术队列,纳入2326例患者,评估术前及术后6、12个月阿片使用和慢性疼痛。
主要发现
- 术前阿片使用率5.5%,术后6个月4.4%,术后12个月3.5%(P<0.001)。
- 术前、术后6个月、术后12个月慢性疼痛发生率分别为41.2%、41.8%、34.7%(P<0.001)。
- 术后12个月阿片使用率:与手术无关慢性疼痛组22.3%,与手术相关慢性疼痛组8.3%,慢性术后疼痛组1.5%(P<0.001)。
- 新发阿片使用者总体1.1%,与手术无关组7.1%,相关组2.3%,慢性术后疼痛组0.7%(P<0.001)。
- 术后12个月阿片使用与术前阿片使用相关,估计比值比28.3(95%CI 14.1-56.7),P<0.001。
临床怎么用
- 术前应评估阿片使用史及慢性疼痛类型,以识别术后长期阿片使用高风险患者。
- 对与手术无关的慢性疼痛患者需加强术后疼痛管理及阿片使用监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term opioid use after surgery is a crucial healthcare problem in North America. Data from European hospitals are scarce and differentiation of chronic pain has rarely been considered. METHODS: In a mixed surgical cohort of the PAIN OUT registry, opioid use and chronic pain were evaluated before surgery, and 6 and 12 months after surgery (M6/M12). Subgroups with or without opioid medication and pre-existing chronic pain were analysed. M12-chronic pain was categorised as chronic postsurgical pain (CPSP) meeting the ICD-11 definition, chronic pain related to surgery not meeting the ICD-11 definition, and chronic pain unrelated to surgery. Primary endpoint was the rate of M12 opioid users. Variables associated with M12 opioid use and patient-reported outcomes were evaluated. RESULTS: Of 2326 patients, 5.5% were preoperative opioid users; 4.4% and 3.5% took opioids at M6 and M12 (P<0.001). Chronic pain before operation and at M6/M12 was reported by 41.2%, 41.8%, and 34.7% of patients, respectively (P<0.001). The rate of M12 opioid users was highest in group unrelated (22.3%; related 8.3%, CPSP 1.5%; P<0.001). New opioid users were 1.1% (unrelated 7.1%, related 2.3%, CPSP 0.7%; P<0.001). M12 opioid users reported more pain, pain-related physical and affective interference, and needed more opioids than non-users. The predominant variable associated with M12 opioids was preoperative opioid use (estimated odds ratio [95% confidence interval]: 28.3 [14.1-56.7], P<0.001). CONCLUSIONS: Opioid use was low in patients with CPSP, and more problematic in patients with chronic pain unrelated to surgery. A detailed assessment of chronic pain unrelated or related to surgery or CPSP is necessary. CLINICAL TRIAL REGISTRATION: NCT02083835.
引用
- Hofer DM, Harnik M, Lehmann T, et al. Trajectories of pain and opioid use up to one year after surgery: analysis of a European registry. Br J Anaesth. 2024. PMID: 38212183. doi:10.1016/j.bja.2023.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。